{"DataElement":{"publicId":"3320074","version":"1","preferredName":"Minor Component Malignant Neoplasm Intratumoral Heterogeneity Mitotic Count Score Text","preferredDefinition":"Numeric range and score that represents the mitoses counted microscopically per high power field of a minor component with intratumoral morphologic heterogeneity characteristics.","longName":"3320069v1.0:3316567v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3320069","version":"1","preferredName":"Minor Element Malignant Neoplasm Intratumoral Heterogeneity Mitotic Count","preferredDefinition":"Lesser or smaller in amount, extent, or size._An artifact that is one of the individual parts of which a composite entity is made up; especially a part that can be separated from or attached to a system._A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004 _Within a tumor._The quality or state of consisting of elements that are not of the same kind or nature._The number of mitoses identified under the microscope in tumors.  It is one of the parameters that determine the grade of malignant tumors.  The method of counting varies, according to the specific tumor examined.  Usually the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields.","longName":"3320057v1.0:3320067v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3320057","version":"1","preferredName":"Minor Element Malignant Neoplasm","preferredDefinition":"Lesser or smaller in amount, extent, or size.:An artifact that is one of the individual parts of which a composite entity is made up; especially a part that can be separated from or attached to a system.:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C45367:C48792:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Minor","conceptCode":"C45367","definition":"Lesser or smaller in amount, extent, or size.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Element","conceptCode":"C48792","definition":"An artifact that is one of the individual parts of which a composite entity is made up; especially a part that can be separated from or attached to a system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B31CE3A1-C663-30FC-E040-BB89AD433C21","latestVersionIndicator":"Yes","beginDate":"2011-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-02","modifiedBy":"ONEDATA","dateModified":"2011-12-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3320067","version":"1","preferredName":"Intratumoral Heterogeneous Mitotic Count","preferredDefinition":"Within a tumor.:The quality or state of consisting of elements that are not of the same kind or nature.:The number of mitoses identified under the microscope in tumors. It is one of the parameters that determine the grade of malignant tumors. The method of counting varies, according to the specific tumor examined. Usually the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields.","longName":"C28036:C28359:C47864","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intratumoral","conceptCode":"C28036","definition":"Within a tumor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Heterogeneity","conceptCode":"C28359","definition":"The quality or state of consisting of elements that are not of the same kind or nature.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Mitotic Count","conceptCode":"C47864","definition":"The number of mitoses identified under the microscope in tumors.  It is one of the parameters that determine the grade of malignant tumors.  The method of counting varies, according to the specific tumor examined.  Usually the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B31D1D30-AB27-B3F1-E040-BB89AD435542","latestVersionIndicator":"Yes","beginDate":"2011-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-02","modifiedBy":"ONEDATA","dateModified":"2011-12-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B31D1D30-AB38-B3F1-E040-BB89AD435542","latestVersionIndicator":"Yes","beginDate":"2011-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-02","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Released per approval by M.Sheth. mc 12/14/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3316567","version":"1","preferredName":"Mitotic Count Score Text","preferredDefinition":"The number of mitoses identified under the microscope in tumors. It is one of the parameters that determine the grade of malignant tumors. The method of counting varies, according to the specific tumor examined. Usually the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields._A number or range of numeric values measuring performance, function, quality, or ability._Text; the words of something written.","longName":"3316567v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"26","maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"not applicable (no minor component)","valueDescription":"None or Not Applicable","ValueMeaning":{"publicId":"3320040","version":"1","preferredName":"None or Not Applicable","longName":"3320040","preferredDefinition":"A term used to indicate that information on a specific question or subject can not be provided because there is no relevance.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"None or Not Applicable","conceptCode":"C18902","definition":"A term used to indicate that information on a specific question or subject can not be provided because there is no relevance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B31C90A0-F6E7-977D-E040-BB89AD4330E1","latestVersionIndicator":"Yes","beginDate":"2011-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B31C90A0-F720-977D-E040-BB89AD4330E1","beginDate":"2011-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-02","modifiedBy":"ONEDATA","dateModified":"2011-12-02","deletedIndicator":"No"},{"value":"Score cannot be determined (NA)","valueDescription":"score cannot be determined (NA)","ValueMeaning":{"publicId":"3316556","version":"1","preferredName":"score cannot be determined (NA)","longName":"3316556","preferredDefinition":"score cannot be determined (NA)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2EB4110-6048-9AD1-E040-BB89AD4354C9","latestVersionIndicator":"Yes","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2EB4110-61E4-9AD1-E040-BB89AD4354C9","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"ONEDATA","dateModified":"2011-11-29","deletedIndicator":"No"},{"value":">10 per 10 HPF (score = 3)","valueDescription":">10 per 10 HPF (score = 3)","ValueMeaning":{"publicId":"3316568","version":"1","preferredName":">10 per 10 HPF (score = 3)","longName":"3316568","preferredDefinition":">10 per 10 HPF (score = 3)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2EB4110-61EE-9AD1-E040-BB89AD4354C9","latestVersionIndicator":"Yes","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2EB4110-6207-9AD1-E040-BB89AD4354C9","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"ONEDATA","dateModified":"2011-11-29","deletedIndicator":"No"},{"value":"6 to 10 per 10 HPF (score = 2)","valueDescription":"6 to 10 per 10 HPF (score = 2)","ValueMeaning":{"publicId":"3316569","version":"1","preferredName":"6 to 10 per 10 HPF (score = 2)","longName":"3316569","preferredDefinition":"6 to 10 per 10 HPF (score = 2)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2EB4110-6211-9AD1-E040-BB89AD4354C9","latestVersionIndicator":"Yes","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2EB4110-622A-9AD1-E040-BB89AD4354C9","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"ONEDATA","dateModified":"2011-11-29","deletedIndicator":"No"},{"value":"0 to 5 per 10 HPF (score = 1)","valueDescription":"0 to 5 per 10 HPF (score = 1)","ValueMeaning":{"publicId":"3316570","version":"1","preferredName":"0 to 5 per 10 HPF (score = 1)","longName":"3316570","preferredDefinition":"0 to 5 per 10 HPF (score = 1)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2EB4110-6234-9AD1-E040-BB89AD4354C9","latestVersionIndicator":"Yes","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B2EB4110-624D-9AD1-E040-BB89AD4354C9","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"ONEDATA","dateModified":"2011-11-29","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3316566","version":"1","preferredName":"Mitotic Count Score Text","preferredDefinition":"The number of mitoses identified under the microscope in tumors. It is one of the parameters that determine the grade of malignant tumors. The method of counting varies, according to the specific tumor examined. Usually the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields.:A number or range of numeric values measuring performance, function, quality, or ability.:Text; the words of something written.","longName":"C47864:C25338:C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mitotic Count","conceptCode":"C47864","definition":"The number of mitoses identified under the microscope in tumors.  It is one of the parameters that determine the grade of malignant tumors.  The method of counting varies, according to the specific tumor examined.  Usually the mitotic count is determined based on the number of mitoses per high power field (40X) or 10 high power fields.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2EB4110-61B2-9AD1-E040-BB89AD4354C9","latestVersionIndicator":"Yes","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"ONEDATA","dateModified":"2011-11-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2EB4110-61C3-9AD1-E040-BB89AD4354C9","latestVersionIndicator":"Yes","beginDate":"2011-11-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-11-29","modifiedBy":"COOPERM","dateModified":"2011-12-14","changeDescription":"Released per approval by M.Sheth. mc 12/14/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044924","version":"1","longName":"Inactive CDEs as of March 2017","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Mitotic count of minor compon","type":"Preferred Question Text","description":"Mitotic count of minor component in cases with intratumoral heterogeneity","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B31D1D30-AC0A-B3F1-E040-BB89AD435542","latestVersionIndicator":"Yes","beginDate":"2011-12-02","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-12-02","modifiedBy":"TSESU","dateModified":"2018-07-18","changeDescription":"Released per approval by M.Sheth. mc 12/14/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}